Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan · Delayed Price · Currency is TWD 267.50
+4.50 (1.71%)
Feb 11, 2026, 1:30 PM CST
Alar Pharmaceuticals Revenue
Alar Pharmaceuticals had revenue of 1.25M TWD in the twelve months ending September 30, 2025, down -99.74% year-over-year. In the year 2024, Alar Pharmaceuticals had annual revenue of 5.82M, down -98.76%.
Revenue (ttm)
1.25M
Revenue Growth
-99.74%
P/S Ratio
14,260.97
Revenue / Employee
46.41K
Employees
27
Market Cap
17.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.82M | -463.46M | -98.76% |
| Dec 31, 2023 | 469.27M | 468.47M | 58,559.00% |
| Dec 31, 2022 | 800.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 600.00K | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grape King Bio | 10.40B |
| YungShin Global Holding | 8.37B |
| Standard Chemical & Pharmaceutical | 6.91B |
| TTY Biopharm Company | 6.50B |
| Synmosa Biopharma | 6.11B |
| Formosa Laboratories | 4.90B |
| ScinoPharm Taiwan | 3.19B |
| Handa Pharmaceuticals | 1.62B |